Measuring tumor DNA in blood samples from ovarian cancer patients
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at blood samples from people with ovarian cancer to measure a marker called ctDNA (bits of tumor DNA in the blood). The goal is to see if changes in this marker before and after surgery can help predict or monitor the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have epithelial ovarian cancer (not the mucinous type).
- You have stored blood samples from before surgery and another from 4 to 7 weeks after surgery, with at least 4 ml of plasma each time.
- You had surgery with the goal of removing all visible cancer (no residual disease).
- You have been followed for at least 6 months after surgery.
- You have not had another cancer diagnosis in the past 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
This trial uses a small piece of your cancer tissue (taken during surgery) to grow 'mini-tumors' in the lab. These help doctors find which treatments might work best for you. It is for people with advanced serous ovarian cancer.
This study uses a simple blood test to look for tiny amounts of cancer DNA after you've finished your first treatment. It aims to see if this test can predict whether the cancer might come back, which could help guide future care.
This study is testing a new blood test that looks for DNA changes to help detect ovarian cancer earlier. You would give a blood sample before your planned surgery or biopsy, and researchers will compare the test results with your pathology report to see how accurate it is.
This trial studies whether a simple blood test (liquid biopsy) can help tell if an ovarian mass is cancer or not, and if it can catch cancer early. If you're going to have surgery for a suspicious ovarian mass, this test might give extra information to guide your care.
This study uses a custom lab test on blood (and tumor tissue) to track ovarian cancer returning and to see how well treatment is working. It may help your care team monitor changes over time, especially after certain surgeries.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.